thelancet.com
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trial
Among all participants with HIV-related sepsis, 28-day mortality was not significantly
reduced with immediate or high-dose antituberculosis therapy. In the subgroup with
later confirmed tuberculosis, ...